174 related articles for article (PubMed ID: 34782599)
41. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
42. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.
Yu J; Huang C; Sun Y; Su X; Cao H; Hu J; Wang K; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Hu Y; Liu H; Zheng C; Li P; Xie J; Liu F; Li Z; Zhao G; Yang K; Liu C; Li H; Chen P; Ji J; Li G;
JAMA; 2019 May; 321(20):1983-1992. PubMed ID: 31135850
[TBL] [Abstract][Full Text] [Related]
43. Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.
Zheng CH; Lu J; Huang CM; Li P; Xie JW; Wang JB; Lin JX
Hepatogastroenterology; 2014 Oct; 61(135):1876-82. PubMed ID: 25713882
[TBL] [Abstract][Full Text] [Related]
44. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
Ilhan E; Alemdar A; Ureyen O; Bas K
J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
[TBL] [Abstract][Full Text] [Related]
45. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
[TBL] [Abstract][Full Text] [Related]
46. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
[TBL] [Abstract][Full Text] [Related]
47. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
Langenbecks Arch Surg; 2021 Jun; 406(4):1071-1080. PubMed ID: 33611693
[TBL] [Abstract][Full Text] [Related]
48. Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.
Chen X; Feng X; Wang M; Yao X
Eur J Surg Oncol; 2020 Nov; 46(11):1998-2010. PubMed ID: 32758382
[TBL] [Abstract][Full Text] [Related]
49. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
Coccolini F; Catena F; Glehen O; Yonemura Y; Sugarbaker PH; Piso P; Ceresoli M; Montori G; Ansaloni L
Eur J Surg Oncol; 2016 Sep; 42(9):1261-7. PubMed ID: 27134147
[TBL] [Abstract][Full Text] [Related]
50. When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?
Miyashiro I; Takachi K; Doki Y; Ishikawa O; Ohigashi H; Murata K; Sasaki Y; Imaoka S; Nakaizumi A; Takenaka A; Furukawa H; Hiratsuka M
World J Surg; 2005 Sep; 29(9):1131-4. PubMed ID: 16086213
[TBL] [Abstract][Full Text] [Related]
51. Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study.
Liang Y; Zhao L; Chen H; Lin T; Chen T; Zhao M; Hu Y; Yu J; Liu H; Li G
BMC Cancer; 2021 Feb; 21(1):196. PubMed ID: 33632161
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
53. Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer.
Oh SE; An JY; Choi MG; Sohn TS; Bae JM; Kim S; Lee JH
Eur J Surg Oncol; 2020 Jul; 46(7):1262-1268. PubMed ID: 32234324
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
[TBL] [Abstract][Full Text] [Related]
55. Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes.
Olmi S; Giorgi R; Cioffi SPB; Uccelli M; Villa R; Ciccarese F; Scotto B; Castello G; Legnani G; Cesana G
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):278-285. PubMed ID: 29135363
[TBL] [Abstract][Full Text] [Related]
56. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.
Inokuchi M; Nakagawa M; Tanioka T; Okuno K; Gokita K; Kojima K
Surg Endosc; 2018 Feb; 32(2):735-742. PubMed ID: 28726137
[TBL] [Abstract][Full Text] [Related]
57. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
58. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.
Takahashi N; Kanda M; Yoshikawa T; Takiguchi N; Fujitani K; Miyamoto K; Ito Y; Takayama O; Imano M; Mitsumori N; Sakamoto J; Morita S; Kodera Y
Gastric Cancer; 2018 Nov; 21(6):1014-1023. PubMed ID: 29536296
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
[TBL] [Abstract][Full Text] [Related]
60. Predictors of survival outcome following radical gastrectomy for gastric cancer.
Lui SA; Tan WB; Tai BC; Yong WP; Mu YS; Ti TK; Shabbir A; So J
ANZ J Surg; 2019 Jan; 89(1-2):84-89. PubMed ID: 30690932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
